The AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Innovation and Discovery Grants are designed to support creative, paradigm-shifting ideas in ILC research. The program is open to projects addressing any aspect of basic or clinical research directly related to lobular breast cancer. Priority consideration is given to work on rare ILC subtypes, dormancy, and recurrence, and each award provides $50,000 USD over one year.
Eligibility Criteria:
- Projects must focus on invasive lobular carcinoma (ILC).
- Applications may address basic or clinical research directly related to lobular breast cancer.
- Priority is given to proposals studying rare ILC subtypes, dormancy, or recurrence.
Funding Details:
- $50,000 USD total.
- 1-year grant term.
- Start of grant term: July 1, 2026.
Deadline:
- Application deadline: April 9, 2026, 1:00 PM ET. ,
- Decision date: June 2026. ,
Where to go for further information: